Home Home

Home -> Science -> Conferences -> Chemistry: Frontiers and Challenges, Aligarh, India, 2013 ->

Site search:  Table of Contents

Discovery of novel antitubercular agents: design, synthesis and insights into the binding interactions


Dharmarajsinh N. Ranaa*; Mahesh T. Chhabriab; Nisha K. Shaha; Pathik S. Brahmkshatriyac


a Department of Chemistry, Gujarat University, Ahmedabad; b Department of Pharmaceutical Chemistry, L M College of Pharmacy, Ahmedabad; c Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic and Center for Biomolecules and Complex Systems, Flemingovo na´m. 2, 166 10 Prague 6, Czech Republic

Email: drsynmedchem@gmail.com



Tuberculosis (TB) infection, caused by Mycobacterium tuberculosis, is the second major cause of death due to an infectious disease in adults worldwide with nine million new cases and close to 2.0 million deaths annually.1 On top of this, the recent cases of totally drug-resistant tuberculosis have raised alarming concerns on the existing drug regimen implying urgent need to discover newer antitubercular agents with newer molecular mechanism of action.2 In the present study, we designed and synthesized a series of novel substituted pyrazoline derivatives and evaluated them for their in vitro antitubercular activity against both the viral and multidrug-resistant tuberculosis (MDR-TB) strains showed that most of the target compounds displayed potent activity in the range of MIC ~0.625 to25 μg/mL. Few compound were found to be equipotent to isoniazid against viral strain of MTB (MIC = 0.625 μg/mL). One of the compounds displayed better potency than isoniazid against MDR-TB (MIC = 3.25 μg/mL).Molecular docking provided useful insights into the binding interactions of target compounds in the active site of enoyl-ACP reductase, the molecular target of isoniazid. The docked compounds occupied the same hydrophobic binding pocket and interacted mostly by dispersion interactions with the neighboring residues Met103, Met155, Tyr158, Met199, Ile202, Ile215 and Leu218.


Keywords: Antitubercular, docking, benzoxazole, pyrazoline, enolyl-ACP reductase



1. Chhabria, M.; Patel, S.; Jani, M. Anti-Infect. Agents Med. Chem. 2010, 9, 59103.

2. Udwadia, Z. F.; Amale, R. A.; Ajbani, K. K.; Rodrigues, C. Clin. Infect. Dis. 2012, 54, 579581.